Join to View Full Profile
333 Cottman AvePhiladelphia, PA 19111
Phone+1 215-728-6900
Fax+1 215-214-3779
Dr. Jain is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
Temple University Hospital-Fox Chase Cancer CenterFellowship, Hematology and Medical Oncology, 2010 - 2013- Temple University HospitalResidency, Internal Medicine, 2007 - 2010
Lewis Katz School of Medicine at Temple UniversityClass of 2007
Certifications & Licensure
PA State Medical License 2007 - 2026
American Board of Internal Medicine Medical Oncology
Clinical Trials
- Cabozantinib S-Malate in Treating Patients With Recurrent or Metastatic Endometrial Cancer Start of enrollment: 2013 May 08
- Metformin Hydrochloride, Carboplatin, and Paclitaxel in Treating Patients With Recurrent Ovarian, Fallopian Tube, or Primary Peritoneal Cancer
- Paclitaxel and Carboplatin With or Without Metformin Hydrochloride in Treating Patients With Stage III, IV, or Recurrent Endometrial Cancer Start of enrollment: 2014 Mar 17
- Join now to see all
Publications & Presentations
PubMed
- Population pharmacokinetics and exposure-response relationships of dostarlimab in primary advanced or recurrent endometrial cancer in part 1 of RUBY.Mita Kuchimanchi, Trine Lembrecht Jørgensen, Eva Hanze, Thierry André, Angela Jain
British Journal of Clinical Pharmacology. 2025-03-01 - 9 citationsNCCN Guidelines® Insights: Ovarian Cancer/Fallopian Tube Cancer/Primary Peritoneal Cancer, Version 3.2024.Joyce Liu, Andrew Berchuck, Floor J Backes, Joshua Cohen, Rachel Grisham
Journal of the National Comprehensive Cancer Network. 2024-10-01 - Endometrial Cancer Treatment: Long-Term Engagement Strategies.Krisha J Howell, Angela Jain
International Journal of Radiation Oncology, Biology, Physics. 2024-02-01
Press Mentions
Biggest Cervical Cancer Drug Advance in 20 YearsNovember 2nd, 2023
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
